glp-1 gip zepbound vs Semaglutide vs Wegovy Tirzepatide (Zepbound)

Hypercoagulability in sickle cell disease and beta-thalassemia

To minimise gastrointestinal risks: Take ibuprofen with or after food Use the lowest effective dose for the shortest duration necessary Avoid exceeding 1,200 mg daily (for over-the-counter use) unless advised by a clinician Consider gastric protection (e.g., proton pump inhibitors) if prolonged use is necessary or if risk factors for peptic ulceration exist, as per NICE guidance Maintain good hydration, particularly if experiencing Wegovy-related gastrointestinal effects Special considerations apply to certain groups: Pregnancy and breastfeeding : Ibuprofen should be avoided during pregnancy, particularly after 20 weeks, unless specifically advised by a doctor

They are often researched for different, though sometimes overlapping, purposes

Under standard review times, MHRA approval would be anticipated in late 2027 or mid-2028